Menu

BioRestorative Therapies, Inc. BRTX

Full chart Compare
Set alert

Price alert · BRTX

All alert types
1.52 USD +0.01 (+0.66%)

At closeNov 6, 2026, 5:57 PM EST

1.45 -0.07 -4.61%

After hours · Nov 6, 5:57 PM ET

1.48 Day range 1.54
1.04 52-week range 24.40
YTD
+29.91%
1 year
+8.57%

Revenue & Expenses

Other Income → Expenses: $1.41MExpenses → Selling, General & Admin: $5.89MExpenses → Research & Development: $10.09MGross Profit → Expenses: $335.86KRevenue → Gross Profit: $335.86KRevenue → Cost of Revenue: $23.84KNet Loss → Expenses: $14.24MOther Income$1.41MGross Profit$335.86KNet Loss$14.24MCost of Revenue$23.84KExpenses$15.98MSelling, General & Admin$5.89MResearch & Development$10.09MRevenue$359.70K

Latest period ending Dec 31, 2025 · select a line to chart its full history

BRTX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
359.70K401.00K145.80K119.80K46.00K
335.86K372.93K145.80K119.80K46.00K
-15.65M-11.56M-15.22M-18.97M-26.31M
-14.24M-8.98M-10.42M-13.22M-44.30M
-31.60-23.20-49.40-73.00-746.00
BRTX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.51M547.89K884.38K1.71M21.03M
4.08M12.28M12.61M16.43M22.45M
3.72M3.75M2.61M6.14M856.50K
356.74K8.53M10.00M10.29M21.60M
BRTX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-10.79M-8.23M-6.43M-5.91M-3.33M
8.90M514.53K3.25M-13.40M-30.66K
2.85M7.38M2.35M021.32M
-116.07K-106.19K-171.04K-265.22K-30.66K
963.30K-336.49K-829.39K-19.31M17.96M